The Global Biotech & Pharma Patent (China) Summit 2026 will bring together leading pharmaceutical companies, biotech firms, research institutions, law firms, intellectual property agencies, and industry experts from around the world. Centered on the core theme of "Focus on APAC Global Vision,Guided by Insight, Innovation Without Borders," and the summit will delve into patent strategies for cutting-edge technologies, global patent deployment and management, cross-border licensing and collaboration, as well as the latest trends in policies and ethics.We are in an era of global health revolution driven by biotechnological innovation. From gene editing to AI-driven drug discovery, disruptive technologies are redefining pharmaceutical R&D. In this process, intellectual property—particularly patents—serves not only as a legal shield but also as a core strategic asset determining the value of technology transfer and global collaboration.China has emerged as an indispensable presence in this landscape. With substantial R&D investment and a maturing ecosystem, it has transitioned from a "fast follower" to a "parallel leader," contributing original achievements across multiple fields while deepening global collaboration.However, the global patent landscape is increasingly complex, with regional differences in examination, cross-border enforcement challenges, and new models like open-source licensing. These demand more sophisticated IP strategies. Key questions now are: How to build a patent system combining international vision with local expertise? How to accelerate innovation through strategic IP management? The answers will determine the biopharmaceutical industry's success in the coming decade. These points are precisely part of the original intent behind hosting this summit and part of the key topics to be discussed with relevant professionals. Join us on Jun 4th-5th! Register now to reserve your place at this exclusive event. Agenda Overview: Day 1 Morning:The integration and challenges of regulatory science and the patent systemü Latest Practices and Future Prospects of Drug Data Protection and Market Exclusivity Systemsü How to Optimize Application Strategies and Quality Management of Biopharmaceutical Patents under the Fast-Track Patent Examination Systemü Patent Challenges in the ADC/Bispecific Antibody 2.0 Eraü A New Balance Under Global Competition and Cooperation: Challenges, Evolution, and Multinational Corporate Strategies of Biopharmaceutical Patent Linkage SystemsDay 1 Afternoon:Maximizing Patent Value and New Commercialization Modelsü Biosimilar Patent Challenge Strategies and Patent Cliff Managementü Patent Due Diligence and Investment Risksü Trade Secrets vs. Patent Trademarks: Biopharmaceutical Innovation Protection Strategies in High-Risk Litigationü Maximizing Innovation Value Using a Composite Intellectual Property Strategy (Patent + Data Protection)ü Intellectual Property Risks and Management in the Context of Supply Chain Restructuring and Digital Therapy ComplianceDay 2 Morning:Global Perspective on Biopharmaceutical R&D and Patent Strategies and Competitionü How to Develop Differentiated Claim Strategies to Cope with Strict Inventiveness/Obviousness Examinations in Various Countriesü Patent Issues and Intellectual Property Risk Prevention in Cross-Border Biopharmaceutical Collaborationü Patent Layout and Cross-Border Expansion Strategies for Pharmaceutical Companiesü Patent Issues in Cross-Border Biopharmaceutical Collaboration and Strategies for Protecting Pharmaceutical Intellectual PropertyDay 2 Afternoon:Opportunities and Legal Challenges of AI in Biotechnology and Pharmaceutical Intellectual Propertyü Patent Challenges and Strategies for AI-Driven Drug Discovery, Gene Editing, and Cell and Gene Therapyü Patent Eligibility and Data Protection in AI-Driven Drug Developmentü Balance and Development of Innovative and Generic Drugs under the Drug Patent Linkage Systemü Deep Integration of AI in Drug Development and Intellectual Property Protection Strategies More details about the topics, please find attached agenda. Partial inviting Companies & Institutions : CNIPAEUIPOWIPOPhIRDAEli Lilly and CompanyNovo NordiskJohnson & JohnsonAbbVieMerck Sharp & DohmeRocheAstraZenecaNovartisPfizerAmgenSanofiGileadSciencesBristol-Myers SquibbVertex PharmaceuticalsRegeneron PharmaceuticalsNovo NordiskChugai PharmaceuticalGSKMerck KGaASun PharmaceuticalCVS HealthDaiichi SankyōLONZATakeda PharmaceuticalHengrui PharmaceuticalsUCBArgenxAlnylam Pharmaceuticals IncCelltrionOtsuka HoldingsGalderma GroupTEVAWuXi AppTecWest PharmaceuticalBeiGeneBiogen IncLabCorpBayerDivis LaboratoriesSandozICONAstellas PharmaModernaBaxterNeurocrine BiosciencesCipla Ltd.,ViatrisHansoh PharmDr. Reddy'sLupin LimitedServierIncyte, CorpGenmabEisaiLuoxin Pharmaceutical GroupCSPC PharmaTide PharmaceuticalBRILLIANT PHARMACEUTICALInnovent BiologicsBio-Thera SolutionsSalubris PharmaceuticalsHaiscom pharmaceuticalEaston BiopharmaceuticalsHua MedicineGenscript CorporationTransThera BiosciencesCHIPSCREEN BIOSCIENCESHumanwell PharmaceuticalFosun Kite BiotechnologyHybio PharmaceuticalAllist PharmaceuticalsXiangxue Life SciencesHumanwell HealthcareXuanZhu PharmaStaidsonShineway PharmaceuticalKanghong PharmaceuticalI-Mab BiopharmaCRDCNew Era PharmaceuticalAscentage PharmaARSUAMOONJiangxi Jemincare GroupYangzijiang PharmaceuticalLintonPharm Co., Ltd.Grand PharmaceuticalQilu PharmaceuticalShanghai PharmaceuticalsKelun PharmaceuticalBuchang PharmaceuticalsLivzon PharmaceuticalSunshineLakeHuahai PharmaceuticalConba Pharmaceutical3SBio Inc.Jiuzhou PharmaceuticalHisun PharmaceuticalSimcere PharmaceuticalBeijing Intellectual Property CourtShanghai Technology ExchangeNhwa Pharmaceutical Tongyuankang PharmaceuticalKangma BiotechnologyRege BiotechZhejiang BaiChengPharmaceuticalTongji UniversityHitGen Inc.Impact TherapeuticsHutchison China MediTechCR Double CraneSinocelltech Gendicine BiopharmaceuticalShenyang Xingqi PharmaceuticalImpact TherapeuticsAsieris PharmaceuticalsMetseraLaNova MedicinesInnolake BiopharmChengdu Guowei BiologicalRibo Life Science Johnson & Johnson MedTechAdlai NortyeKejun PharmaceuticalBeijing Wuhe Boao PharmaceuticalYoujia (Hangzhou) BiotechnologyLyvgen BiopharmaMabwell (Shanghai) BioscienceIASO BioTOT BiopharmSuzhou Gelanke PharmaceuticalBioNTechSanegeneBioMedical Academy of Sciences & ResearchKangbaida (Sichuan) BiologicalShanghai Luoqi BiotechnologyYuekang Kechuang PharmaceuticalSunshineLakeKelun-Bota BiotechChina Biologic ProductsJunhemeng BiotechXiamen Amoytop BiotechYuansong BiotechnologyWuXi BiologicsJ Xinnian PharmaceuticalShanghai Yunsheng Yanxin BiotechSimcere Pharmaceuticalwebsite://en.zvuaz.cn/p/1176775/
引(yin)言隨(sui)(sui)著汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)產(chan)(chan)(chan)業(ye)(ye)(ye)向(xiang)(xiang)“新(xin)(xin)(xin)四化(hua)(hua)”(電(dian)(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)化(hua)(hua)、智(zhi)能(neng)(neng)(neng)化(hua)(hua)、網聯(lian)(lian)化(hua)(hua)、共享化(hua)(hua))深度轉(zhuan)(zhuan)型(xing)(xing),其(qi)(qi)競爭(zheng)(zheng)核心(xin)已(yi)從(cong)傳(chuan)統(tong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)機(ji)械制造(zao)轉(zhuan)(zhuan)變為(wei)(wei)(wei)(wei)芯(xin)片(pian)、軟(ruan)件(jian)、電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)和(he)(he)(he)(he)智(zhi)能(neng)(neng)(neng)算(suan)(suan)(suan)法(fa)(fa)(fa)(fa)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)比拼。這(zhe)(zhe)使得知(zhi)識(shi)產(chan)(chan)(chan)權(quan)(quan)(IP)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)車(che)(che)(che)(che)(che)(che)企(qi)(qi)*關(guan)鍵的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)資(zi)(zi)產(chan)(chan)(chan)和(he)(he)(he)(he)護(hu)城河(he),同(tong)時(shi)也引(yin)發(fa)(fa)(fa)(fa)了(le)(le)(le)全球(qiu)范圍內(nei)日(ri)益頻繁(fan)且復雜(za)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)知(zhi)識(shi)產(chan)(chan)(chan)權(quan)(quan)糾(jiu)紛(fen)(fen)(fen)。本(ben)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)集收(shou)錄了(le)(le)(le)2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)至2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)間(jian)具有(you)代(dai)(dai)表(biao)性(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)全球(qiu)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)IP糾(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)。一、 電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)與(yu)(yu)電(dian)(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)車(che)(che)(che)(che)(che)(che)核心(xin)**糾(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)1:LG化(hua)(hua)學(xue)(xue) vs. SK創(chuang)(chuang)新(xin)(xin)(xin) (2020-2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian))時(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)-2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)議(yi)(yi)(yi)(yi)領(ling)域(yu)(yu)(yu)(yu): 電(dian)(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)(商(shang)(shang)(shang)(shang)業(ye)(ye)(ye)秘(mi)密)案(an)(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)摘(zhai)(zhai)要(yao)(yao)(yao): 韓國(guo)(guo)兩(liang)大(da)(da)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)巨(ju)頭在(zai)美(mei)(mei)國(guo)(guo)爆發(fa)(fa)(fa)(fa)激烈法(fa)(fa)(fa)(fa)律戰(zhan)(zhan)。LG化(hua)(hua)學(xue)(xue)(現為(wei)(wei)(wei)(wei)LG能(neng)(neng)(neng)源(yuan)解(jie)決方(fang)(fang)案(an)(an)(an)(an)(an)(an)(an)(an))指(zhi)(zhi)(zhi)控SK創(chuang)(chuang)新(xin)(xin)(xin)(SK Innovation)通(tong)過雇(gu)傭其(qi)(qi)前員(yuan)工竊(qie)取(qu)了(le)(le)(le)大(da)(da)量(liang)與(yu)(yu)電(dian)(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)相(xiang)關(guan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)商(shang)(shang)(shang)(shang)業(ye)(ye)(ye)秘(mi)密,包(bao)(bao)括(kuo)關(guan)于鋰(li)(li)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)隔膜的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)關(guan)鍵技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)。糾(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 美(mei)(mei)國(guo)(guo)國(guo)(guo)際貿易委員(yuan)會(hui)(ITC)于2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)(yue)作(zuo)出*終(zhong)裁決,對(dui)(dui)(dui)(dui)(dui)SK創(chuang)(chuang)新(xin)(xin)(xin)發(fa)(fa)(fa)(fa)出為(wei)(wei)(wei)(wei)期10年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)禁(jin)止令,禁(jin)止其(qi)(qi)向(xiang)(xiang)美(mei)(mei)國(guo)(guo)進(jin)口(kou)電(dian)(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)、模(mo)(mo)(mo)塊、電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)包(bao)(bao)及相(xiang)關(guan)零部件(jian)。*終(zhong),在(zai)拜登(deng)政府(fu)介入(ru)(ru)和(he)(he)(he)(he)雙(shuang)(shuang)方(fang)(fang)壓力(li)下(xia),2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue),雙(shuang)(shuang)方(fang)(fang)達(da)(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)。SK創(chuang)(chuang)新(xin)(xin)(xin)向(xiang)(xiang)LG支(zhi)付(fu)2萬(wan)億韓元(yuan)(約18億美(mei)(mei)元(yuan))的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)賠(pei)(pei)償(chang)(chang)金(jin)(包(bao)(bao)括(kuo)現金(jin)和(he)(he)(he)(he)版稅),并(bing)撤回(hui)相(xiang)關(guan)訴(su)訟(song)。來(lai)(lai)(lai)源(yuan):United States International Trade Commission. (2021). Certain Lithium Ion Batteries, Battery Cells, Battery Modules, Battery Packs, Components Thereof, and Processes Therefor. Investigation No. 337-TA-1159.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)11日(ri)). LG Energy, SK Innovation reach settlement in battery dispute.案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)2:寧(ning)德時(shi)代(dai)(dai) vs. 中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航(hang)(hang) (2022年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian))時(shi)間(jian): 2022年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)議(yi)(yi)(yi)(yi)領(ling)域(yu)(yu)(yu)(yu): 鋰(li)(li)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)結(jie)(jie)構(gou)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)**(正極(ji)極(ji)片(pian)、防爆閥(fa)等(deng)(deng)(deng)(deng)(deng))案(an)(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)摘(zhai)(zhai)要(yao)(yao)(yao): 中(zhong)(zhong)國(guo)(guo)動(dong)(dong)(dong)(dong)力(li)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)巨(ju)頭寧(ning)德時(shi)代(dai)(dai)(CATL)對(dui)(dui)(dui)(dui)(dui)其(qi)(qi)競爭(zheng)(zheng)對(dui)(dui)(dui)(dui)(dui)手中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航(hang)(hang)(CALB)發(fa)(fa)(fa)(fa)起(qi)多(duo)項**侵(qin)(qin)權(quan)(quan)訴(su)訟(song),指(zhi)(zhi)(zhi)控其(qi)(qi)侵(qin)(qin)犯了(le)(le)(le)包(bao)(bao)括(kuo)“正極(ji)極(ji)片(pian)及電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)”、“防爆裝(zhuang)置”在(zai)內(nei)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)多(duo)項核心(xin)**。此案(an)(an)(an)(an)(an)(an)(an)(an)被(bei)(bei)(bei)視為(wei)(wei)(wei)(wei)中(zhong)(zhong)國(guo)(guo)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)行(xing)(xing)(xing)業(ye)(ye)(ye)史上(shang)*大(da)(da)規模(mo)(mo)(mo)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)**戰(zhan)(zhan)。糾(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 經(jing)過多(duo)輪庭(ting)(ting)審,2023年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian),福(fu)建省(sheng)高(gao)級(ji)人民(min)法(fa)(fa)(fa)(fa)院(yuan)(yuan)(yuan)作(zuo)出終(zhong)審判決,裁定(ding)中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航(hang)(hang)侵(qin)(qin)犯寧(ning)德時(shi)代(dai)(dai)兩(liang)項**,需(xu)立即停止銷(xiao)售侵(qin)(qin)權(quan)(quan)產(chan)(chan)(chan)品,并(bing)賠(pei)(pei)償(chang)(chang)寧(ning)德時(shi)代(dai)(dai)總計(ji)(ji)(ji)(ji)(ji)(ji)約人民(min)幣(bi)5700萬(wan)元(yuan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)經(jing)濟損失。此外(wai),中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航(hang)(hang)還被(bei)(bei)(bei)要(yao)(yao)(yao)求支(zhi)付(fu)高(gao)達(da)(da)數(shu)百(bai)萬(wan)元(yuan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)**許可(ke)(ke)費(fei)。來(lai)(lai)(lai)源(yuan):福(fu)建省(sheng)高(gao)級(ji)人民(min)法(fa)(fa)(fa)(fa)院(yuan)(yuan)(yuan) (2023) 閩(min)民(min)終(zhong)XX號民(min)事判決書(具體案(an)(an)(an)(an)(an)(an)(an)(an)號因公(gong)(gong)開信(xin)(xin)息(xi)(xi)省(sheng)略)。第一財經(jing). (2023年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)(yue)21日(ri)). 《寧(ning)德時(shi)代(dai)(dai)與(yu)(yu)中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航(hang)(hang)**戰(zhan)(zhan)落幕:中(zhong)(zhong)創(chuang)(chuang)新(xin)(xin)(xin)航(hang)(hang)賠(pei)(pei)償(chang)(chang)5700萬(wan)元(yuan)》。二、 自(zi)(zi)動(dong)(dong)(dong)(dong)駕(jia)(jia)駛(shi)與(yu)(yu)智(zhi)能(neng)(neng)(neng)網聯(lian)(lian)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)糾(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)3:Waymo vs. Uber (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)和(he)(he)(he)(he)解(jie)后(hou)延續(xu)(xu)影(ying)響(xiang)(xiang)(xiang))時(shi)間(jian): 2017年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)發(fa)(fa)(fa)(fa)起(qi),2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)達(da)(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)但(dan)影(ying)響(xiang)(xiang)(xiang)持(chi)續(xu)(xu)。爭(zheng)(zheng)議(yi)(yi)(yi)(yi)領(ling)域(yu)(yu)(yu)(yu): 激光(guang)雷達(da)(da)(LiDAR)和(he)(he)(he)(he)自(zi)(zi)動(dong)(dong)(dong)(dong)駕(jia)(jia)駛(shi)商(shang)(shang)(shang)(shang)業(ye)(ye)(ye)秘(mi)密案(an)(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)摘(zhai)(zhai)要(yao)(yao)(yao): 谷(gu)歌(ge)旗下(xia)自(zi)(zi)動(dong)(dong)(dong)(dong)駕(jia)(jia)駛(shi)公(gong)(gong)司(si)Waymo指(zhi)(zhi)(zhi)控其(qi)(qi)前工程(cheng)師Anthony Levandowski在(zai)離(li)職前下(xia)載了(le)(le)(le)超過1.4萬(wan)份機(ji)密文件(jian),并(bing)隨(sui)(sui)后(hou)創(chuang)(chuang)辦了(le)(le)(le)自(zi)(zi)動(dong)(dong)(dong)(dong)駕(jia)(jia)駛(shi)卡車(che)(che)(che)(che)(che)(che)公(gong)(gong)司(si)Otto(后(hou)被(bei)(bei)(bei)Uber收(shou)購),Uber因此使用(yong)了(le)(le)(le)這(zhe)(zhe)些(xie)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)。糾(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 雙(shuang)(shuang)方(fang)(fang)于2018年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)達(da)(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie),但(dan)2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian),該(gai)案(an)(an)(an)(an)(an)(an)(an)(an)有(you)了(le)(le)(le)后(hou)續(xu)(xu)進(jin)展。Anthony Levandowski因盜竊(qie)商(shang)(shang)(shang)(shang)業(ye)(ye)(ye)機(ji)密被(bei)(bei)(bei)美(mei)(mei)國(guo)(guo)法(fa)(fa)(fa)(fa)院(yuan)(yuan)(yuan)判處(chu)18個月(yue)(yue)(yue)監禁(jin)(后(hou)獲特(te)朗(lang)普(pu)特(te)赦)。此案(an)(an)(an)(an)(an)(an)(an)(an)確立了(le)(le)(le)自(zi)(zi)動(dong)(dong)(dong)(dong)駕(jia)(jia)駛(shi)領(ling)域(yu)(yu)(yu)(yu)商(shang)(shang)(shang)(shang)業(ye)(ye)(ye)秘(mi)密保(bao)護(hu)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)極(ji)端(duan)重要(yao)(yao)(yao)性(xing)(xing),為(wei)(wei)(wei)(wei)后(hou)續(xu)(xu)類似案(an)(an)(an)(an)(an)(an)(an)(an)件(jian)提供(gong)了(le)(le)(le)判例(li)(li)(li)(li)。來(lai)(lai)(lai)源(yuan):United States District Court, Northern District of California. Case No. 3:17-cv-00939-WHA.The New York Times. (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)8月(yue)(yue)(yue)5日(ri)). Ex-Google Engineer Avoids Prison After Trump Commutes Sentence.案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)4:特(te)斯(si)(si)拉(la) vs. 小(xiao)鵬(peng)(peng)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che) (2019年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)發(fa)(fa)(fa)(fa)起(qi),2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)和(he)(he)(he)(he)解(jie))時(shi)間(jian): 2019年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)發(fa)(fa)(fa)(fa)起(qi)訴(su)訟(song),2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)達(da)(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)。爭(zheng)(zheng)議(yi)(yi)(yi)(yi)領(ling)域(yu)(yu)(yu)(yu): 自(zi)(zi)動(dong)(dong)(dong)(dong)駕(jia)(jia)駛(shi)源(yuan)代(dai)(dai)碼與(yu)(yu)商(shang)(shang)(shang)(shang)業(ye)(ye)(ye)秘(mi)密案(an)(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)摘(zhai)(zhai)要(yao)(yao)(yao): 特(te)斯(si)(si)拉(la)起(qi)訴(su)其(qi)(qi)前華裔工程(cheng)師曹光(guang)植(zhi),指(zhi)(zhi)(zhi)控其(qi)(qi)在(zai)入(ru)(ru)職小(xiao)鵬(peng)(peng)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)前,將特(te)斯(si)(si)拉(la)自(zi)(zi)動(dong)(dong)(dong)(dong)駕(jia)(jia)駛(shi)系統(tong)Autopilot的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)源(yuan)代(dai)(dai)碼副本(ben)上(shang)傳(chuan)至其(qi)(qi)個人iCloud賬(zhang)戶(hu)。小(xiao)鵬(peng)(peng)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)作(zuo)為(wei)(wei)(wei)(wei)曹光(guang)植(zhi)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)新(xin)(xin)(xin)雇(gu)主(zhu)被(bei)(bei)(bei)卷入(ru)(ru)訴(su)訟(song)。糾(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 經(jing)過長達(da)(da)兩(liang)年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)調查和(he)(he)(he)(he)庭(ting)(ting)審,雙(shuang)(shuang)方(fang)(fang)于2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)達(da)(da)成(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)。特(te)斯(si)(si)拉(la)對(dui)(dui)(dui)(dui)(dui)小(xiao)鵬(peng)(peng)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)共享請求表(biao)示滿意,并(bing)結(jie)(jie)束(shu)了(le)(le)(le)此案(an)(an)(an)(an)(an)(an)(an)(an)。此案(an)(an)(an)(an)(an)(an)(an)(an)凸顯了(le)(le)(le)中(zhong)(zhong)美(mei)(mei)科技(ji)(ji)(ji)(ji)公(gong)(gong)司(si)在(zai)尖(jian)端(duan)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)人才競爭(zheng)(zheng)中(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)IP沖突。來(lai)(lai)(lai)源(yuan):United States District Court, Northern District of California. Case No. 3:19-cv-01463-RS.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)16日(ri)). Tesla settles lawsuit against engineer who moved to Xpeng Motors.(預(yu)測) 案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)5:某科技(ji)(ji)(ji)(ji)公(gong)(gong)司(si) vs. 某傳(chuan)統(tong)車(che)(che)(che)(che)(che)(che)企(qi)(qi) (2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)預(yu)測)時(shi)間(jian): 2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(預(yu)測)爭(zheng)(zheng)議(yi)(yi)(yi)(yi)領(ling)域(yu)(yu)(yu)(yu): 大(da)(da)模(mo)(mo)(mo)型(xing)(xing)在(zai)智(zhi)能(neng)(neng)(neng)座(zuo)艙(cang)中(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)應(ying)用(yong)**案(an)(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)摘(zhai)(zhai)要(yao)(yao)(yao): 隨(sui)(sui)著生(sheng)(sheng)成(cheng)(cheng)(cheng)(cheng)式(shi)AI大(da)(da)模(mo)(mo)(mo)型(xing)(xing)在(zai)車(che)(che)(che)(che)(che)(che)載語(yu)(yu)音(yin)助手、場(chang)景化(hua)(hua)服(fu)務中(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)深度集成(cheng)(cheng)(cheng)(cheng),某家(jia)專注(zhu)于AI技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)科技(ji)(ji)(ji)(ji)公(gong)(gong)司(si)(如已(yi)布局(ju)相(xiang)關(guan)**的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)百(bai)度、谷(gu)歌(ge)或(huo)一家(jia)初創(chuang)(chuang)公(gong)(gong)司(si))可(ke)(ke)能(neng)(neng)(neng)會(hui)對(dui)(dui)(dui)(dui)(dui)某家(jia)傳(chuan)統(tong)車(che)(che)(che)(che)(che)(che)企(qi)(qi)巨(ju)頭發(fa)(fa)(fa)(fa)起(qi)**侵(qin)(qin)權(quan)(quan)訴(su)訟(song),指(zhi)(zhi)(zhi)控其(qi)(qi)智(zhi)能(neng)(neng)(neng)座(zuo)艙(cang)系統(tong)中(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)對(dui)(dui)(dui)(dui)(dui)話式(shi)AI、個性(xing)(xing)化(hua)(hua)推薦(jian)等(deng)(deng)(deng)(deng)(deng)功能(neng)(neng)(neng)侵(qin)(qin)犯了(le)(le)(le)其(qi)(qi)自(zi)(zi)然語(yu)(yu)言處(chu)理(NLP)和(he)(he)(he)(he)機(ji)器學(xue)(xue)習(xi)模(mo)(mo)(mo)型(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)**權(quan)(quan)。潛在(zai)影(ying)響(xiang)(xiang)(xiang): 這(zhe)(zhe)類糾(jiu)紛(fen)(fen)(fen)將把汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)IP戰(zhan)(zhan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)戰(zhan)(zhan)火從(cong)硬(ying)件(jian)、傳(chuan)統(tong)軟(ruan)件(jian)引(yin)向(xiang)(xiang)AI算(suan)(suan)(suan)法(fa)(fa)(fa)(fa)和(he)(he)(he)(he)數(shu)據(ju)處(chu)理層面(mian),可(ke)(ke)能(neng)(neng)(neng)引(yin)發(fa)(fa)(fa)(fa)一系列關(guan)于AI生(sheng)(sheng)成(cheng)(cheng)(cheng)(cheng)內(nei)容版權(quan)(quan)和(he)(he)(he)(he)算(suan)(suan)(suan)法(fa)(fa)(fa)(fa)**有(you)效性(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)新(xin)(xin)(xin)法(fa)(fa)(fa)(fa)律挑(tiao)戰(zhan)(zhan)。三、 軟(ruan)件(jian)與(yu)(yu)用(yong)戶(hu)界面(mian)(UI)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)糾(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)6:寶馬、奔馳等(deng)(deng)(deng)(deng)(deng) vs. **主(zhu)張實體(PAE) (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)至今)時(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)持(chi)續(xu)(xu)至今爭(zheng)(zheng)議(yi)(yi)(yi)(yi)領(ling)域(yu)(yu)(yu)(yu): 車(che)(che)(che)(che)(che)(che)載軟(ruan)件(jian)、通(tong)信(xin)(xin)協議(yi)(yi)(yi)(yi)等(deng)(deng)(deng)(deng)(deng)基礎**案(an)(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)摘(zhai)(zhai)要(yao)(yao)(yao): 多(duo)家(jia)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)制造(zao)商(shang)(shang)(shang)(shang),包(bao)(bao)括(kuo)寶馬、奔馳、大(da)(da)眾等(deng)(deng)(deng)(deng)(deng),持(chi)續(xu)(xu)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)**主(zhu)張實體(Patent Assertion Entities,又稱“**流氓”)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)目標。這(zhe)(zhe)些(xie)PAE大(da)(da)量(liang)收(shou)購與(yu)(yu)3G/4G通(tong)信(xin)(xin)、導(dao)航(hang)(hang)軟(ruan)件(jian)、車(che)(che)(che)(che)(che)(che)輛遠程(cheng)信(xin)(xin)息(xi)(xi)處(chu)理等(deng)(deng)(deng)(deng)(deng)相(xiang)關(guan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)基礎**,然后(hou)向(xiang)(xiang)車(che)(che)(che)(che)(che)(che)企(qi)(qi)發(fa)(fa)(fa)(fa)起(qi)大(da)(da)規模(mo)(mo)(mo)**侵(qin)(qin)權(quan)(quan)訴(su)訟(song),尋求高(gao)額許可(ke)(ke)費(fei)或(huo)賠(pei)(pei)償(chang)(chang)。糾(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 這(zhe)(zhe)是(shi)(shi)(shi)一種(zhong)持(chi)續(xu)(xu)性(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)(xing)業(ye)(ye)(ye)現象(xiang)。車(che)(che)(che)(che)(che)(che)企(qi)(qi)通(tong)常選(xuan)擇達(da)(da)成(cheng)(cheng)(cheng)(cheng)許可(ke)(ke)協議(yi)(yi)(yi)(yi)或(huo)進(jin)行(xing)(xing)(xing)法(fa)(fa)(fa)(fa)庭(ting)(ting)抗辯。例(li)(li)(li)(li)如,2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian),大(da)(da)陸(lu)集團(Continental)在(zai)美(mei)(mei)國(guo)(guo)*高(gao)法(fa)(fa)(fa)(fa)院(yuan)(yuan)(yuan)對(dui)(dui)(dui)(dui)(dui)Avanci等(deng)(deng)(deng)(deng)(deng)**池(chi)發(fa)(fa)(fa)(fa)起(qi)反壟斷訴(su)訟(song),試(shi)圖遏制PAE的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)(xing)為(wei)(wei)(wei)(wei),但(dan)未能(neng)(neng)(neng)成(cheng)(cheng)(cheng)(cheng)功。這(zhe)(zhe)已(yi)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)整個汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)行(xing)(xing)(xing)業(ye)(ye)(ye)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)“隱形成(cheng)(cheng)(cheng)(cheng)本(ben)”。來(lai)(lai)(lai)源(yuan):Juve Patent. (2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)多(duo)次(ci)報道). Avanci, Nokia lawsuits against Daimler and its suppliers.IAM Media. (2022年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)5月(yue)(yue)(yue)10日(ri)). The auto sector’s PAE problem is not going away.四、 設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)與(yu)(yu)商(shang)(shang)(shang)(shang)標糾(jiu)紛(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)7:捷(jie)豹(bao)(bao)路虎 vs. 江(jiang)鈴汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che) (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian))時(shi)間(jian): 2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)議(yi)(yi)(yi)(yi)領(ling)域(yu)(yu)(yu)(yu): 車(che)(che)(che)(che)(che)(che)型(xing)(xing)外(wai)觀(guan)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)案(an)(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)摘(zhai)(zhai)要(yao)(yao)(yao): 捷(jie)豹(bao)(bao)路虎(JLR)在(zai)中(zhong)(zhong)國(guo)(guo)起(qi)訴(su)江(jiang)鈴汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che),指(zhi)(zhi)(zhi)控其(qi)(qi)生(sheng)(sheng)產(chan)(chan)(chan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)陸(lu)風(feng)X7車(che)(che)(che)(che)(che)(che)型(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)外(wai)觀(guan)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)抄襲了(le)(le)(le)路虎攬勝極(ji)光(guang)(Range Rover Evoque)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)獨特(te)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)。糾(jiu)紛(fen)(fen)(fen)結(jie)(jie)果(guo): 北京(jing)(jing)市朝陽區(qu)人民(min)法(fa)(fa)(fa)(fa)院(yuan)(yuan)(yuan)判決捷(jie)豹(bao)(bao)路虎勝訴(su)。法(fa)(fa)(fa)(fa)院(yuan)(yuan)(yuan)裁定(ding)江(jiang)鈴汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)必(bi)須立即停止陸(lu)風(feng)X7的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)所(suo)有(you)銷(xiao)售、制造(zao)和(he)(he)(he)(he)營銷(xiao)行(xing)(xing)(xing)為(wei)(wei)(wei)(wei),并(bing)向(xiang)(xiang)捷(jie)豹(bao)(bao)路虎支(zhi)付(fu)賠(pei)(pei)償(chang)(chang)金(jin)。此案(an)(an)(an)(an)(an)(an)(an)(an)是(shi)(shi)(shi)中(zhong)(zhong)國(guo)(guo)法(fa)(fa)(fa)(fa)院(yuan)(yuan)(yuan)保(bao)護(hu)外(wai)資(zi)(zi)企(qi)(qi)業(ye)(ye)(ye)外(wai)觀(guan)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)產(chan)(chan)(chan)權(quan)(quan)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)標志(zhi)(zhi)(zhi)性(xing)(xing)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)。來(lai)(lai)(lai)源(yuan):北京(jing)(jing)市朝陽區(qu)人民(min)法(fa)(fa)(fa)(fa)院(yuan)(yuan)(yuan) (2019) 京(jing)(jing)0105民(min)初XX號民(min)事判決書。BBC News. (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)3月(yue)(yue)(yue)26日(ri)). Jaguar Land Rover wins Chinese copycat case.(預(yu)測) 案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)8:Cybertruck設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)元(yuan)素(su)爭(zheng)(zheng)議(yi)(yi)(yi)(yi) (2024-2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)預(yu)測)時(shi)間(jian): 2024年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)末-2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(預(yu)測)爭(zheng)(zheng)議(yi)(yi)(yi)(yi)領(ling)域(yu)(yu)(yu)(yu): 標志(zhi)(zhi)(zhi)性(xing)(xing)外(wai)觀(guan)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)案(an)(an)(an)(an)(an)(an)(an)(an)情(qing)(qing)摘(zhai)(zhai)要(yao)(yao)(yao): 隨(sui)(sui)著特(te)斯(si)(si)拉(la)Cybertruck的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)正式(shi)交(jiao)付(fu)和(he)(he)(he)(he)其(qi)(qi)**未來(lai)(lai)(lai)感的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)棱角設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)標志(zhi)(zhi)(zhi),其(qi)(qi)他車(che)(che)(che)(che)(che)(che)企(qi)(qi)(尤(you)其(qi)(qi)是(shi)(shi)(shi)新(xin)(xin)(xin)興電(dian)(dian)(dian)(dian)(dian)(dian)動(dong)(dong)(dong)(dong)車(che)(che)(che)(che)(che)(che)品牌或(huo)小(xiao)眾制造(zao)商(shang)(shang)(shang)(shang))若(ruo)推出類似棱角分明的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)皮卡或(huo)SUV車(che)(che)(che)(che)(che)(che)型(xing)(xing),特(te)斯(si)(si)拉(la)可(ke)(ke)能(neng)(neng)(neng)會(hui)采取(qu)強硬(ying)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)法(fa)(fa)(fa)(fa)律行(xing)(xing)(xing)動(dong)(dong)(dong)(dong),主(zhu)張其(qi)(qi)獨特(te)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)語(yu)(yu)言受保(bao)護(hu),從(cong)而引(yin)發(fa)(fa)(fa)(fa)新(xin)(xin)(xin)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)**糾(jiu)紛(fen)(fen)(fen)。潛在(zai)影(ying)響(xiang)(xiang)(xiang): 這(zhe)(zhe)將測試(shi)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)**在(zai)“非(fei)傳(chuan)統(tong)”造(zao)型(xing)(xing)上(shang)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)保(bao)護(hu)范圍。總結(jie)(jie)與(yu)(yu)趨勢分析主(zhu)戰(zhan)(zhan)場(chang)轉(zhuan)(zhuan)移: 從(cong)傳(chuan)統(tong)內(nei)燃機(ji)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)全面(mian)轉(zhuan)(zhuan)向(xiang)(xiang)電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)、電(dian)(dian)(dian)(dian)(dian)(dian)驅、電(dian)(dian)(dian)(dian)(dian)(dian)控、智(zhi)能(neng)(neng)(neng)座(zuo)艙(cang)和(he)(he)(he)(he)自(zi)(zi)動(dong)(dong)(dong)(dong)駕(jia)(jia)駛(shi)軟(ruan)件(jian)算(suan)(suan)(suan)法(fa)(fa)(fa)(fa)。爭(zheng)(zheng)議(yi)(yi)(yi)(yi)類型(xing)(xing)多(duo)樣化(hua)(hua): 從(cong)**侵(qin)(qin)權(quan)(quan)擴展到商(shang)(shang)(shang)(shang)業(ye)(ye)(ye)秘(mi)密盜竊(qie)、軟(ruan)件(jian)著作(zuo)權(quan)(quan)、UI/UX設(she)(she)計(ji)(ji)(ji)(ji)(ji)(ji)**以及標準(zhun)必(bi)要(yao)(yao)(yao)**(SEP)許可(ke)(ke)費(fei)糾(jiu)紛(fen)(fen)(fen)。主(zhu)體多(duo)元(yuan)化(hua)(hua): 參(can)與(yu)(yu)方(fang)(fang)不再僅是(shi)(shi)(shi)車(che)(che)(che)(che)(che)(che)企(qi)(qi),科技(ji)(ji)(ji)(ji)公(gong)(gong)司(si)、零部件(jian)供(gong)應(ying)商(shang)(shang)(shang)(shang)、電(dian)(dian)(dian)(dian)(dian)(dian)池(chi)制造(zao)商(shang)(shang)(shang)(shang)、**運(yun)營實體(NPEs/PAEs) 都(dou)深度參(can)與(yu)(yu)其(qi)(qi)中(zhong)(zhong)。地域(yu)(yu)(yu)(yu)全球(qiu)化(hua)(hua): 中(zhong)(zhong)美(mei)(mei)歐成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)*主(zhu)要(yao)(yao)(yao)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)IP糾(jiu)紛(fen)(fen)(fen)戰(zhan)(zhan)場(chang),尤(you)其(qi)(qi)是(shi)(shi)(shi)中(zhong)(zhong)國(guo)(guo),隨(sui)(sui)著本(ben)土車(che)(che)(che)(che)(che)(che)企(qi)(qi)和(he)(he)(he)(he)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)公(gong)(gong)司(si)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)崛起(qi),其(qi)(qi)國(guo)(guo)內(nei)和(he)(he)(he)(he)國(guo)(guo)際IP訴(su)訟(song)活(huo)動(dong)(dong)(dong)(dong)顯著增加。和(he)(he)(he)(he)解(jie)成(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)常態: 鑒于訴(su)訟(song)成(cheng)(cheng)(cheng)(cheng)本(ben)高(gao)昂、技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)復雜(za)性(xing)(xing)高(gao)且可(ke)(ke)能(neng)(neng)(neng)影(ying)響(xiang)(xiang)(xiang)供(gong)應(ying)鏈,許多(duo)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)*終(zhong)以和(he)(he)(he)(he)解(jie)和(he)(he)(he)(he)交(jiao)叉許可(ke)(ke)告(gao)終(zhong),但(dan)前提是(shi)(shi)(shi)雙(shuang)(shuang)方(fang)(fang)實力(li)對(dui)(dui)(dui)(dui)(dui)等(deng)(deng)(deng)(deng)(deng)。說(shuo)明: 2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)案(an)(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)(li)基于當前行(xing)(xing)(xing)業(ye)(ye)(ye)動(dong)(dong)(dong)(dong)態和(he)(he)(he)(he)技(ji)(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(shu)(shu)發(fa)(fa)(fa)(fa)展趨勢進(jin)行(xing)(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)合(he)理預(yu)測,旨在(zai)提供(gong)前瞻性(xing)(xing)視角。實際發(fa)(fa)(fa)(fa)生(sheng)(sheng)的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)事件(jian)請以未來(lai)(lai)(lai)官方(fang)(fang)發(fa)(fa)(fa)(fa)布的(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)(de)信(xin)(xin)息(xi)(xi)為(wei)(wei)(wei)(wei)準(zhun)。Ann Tel: +86 021-60778889- 808新(xin)(xin)(xin)能(neng)(neng)(neng)源(yuan)與(yu)(yu)智(zhi)能(neng)(neng)(neng)網聯(lian)(lian)汽(qi)(qi)(qi)(qi)(qi)車(che)(che)(che)(che)(che)(che)知(zhi)識(shi)產(chan)(chan)(chan)權(quan)(quan)創(chuang)(chuang)新(xin)(xin)(xin)峰會(hui)2025組(zu)委會(hui)2025 NEV & ICV IP Innovation Summit//zvuaz.cn/p/554988